ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support...

PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people work tirelessly for clients, offering exceptional experience across all phases, therapeutic areas and a broad spectrum of services.  ...

Premier Research is a leading clinical development service provider that helps highly innovative biotech, specialty pharma, and medical device companies transform breakthrough ideas into reality. The company has a wealth of experience in the...

We are specialists in orphan drug access, partnering with our clients to achieve launch success worldwide. Through our initiatives, we are able to inform and shape the conversation of orphan drugs. Our expert team is specialised in several key areas ...

Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer...

UBC leads the market in providing integrated, comprehensive clinical, safety, and commercialization services. Our experts are committed to working in unison with pharmaceutical and biotech organizations to effectively navigate the product lifecycle...

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions ...

Blue Matter is a strategic management consulting firm serving the biopharmaceutical industry.  The firm supports clients globally from offices throughout North America and Europe.  The Blue Matter team combines industry and scientific knowledge with ...

CRA, Charles River Associates is a leading global consulting firm with a dedicated Life Sciences Practice. Our expertise blends extensive rare disease knowledge with advanced analytics and commercial strategy experience to help pharma, biotech, and...

Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines. Its mission is to deliver the right medicine to the right patient at the right...

MME was established in 2001 and has offices in Oxford, MS; Montclair, NJ; and Oxford, UK. MME's client base includes large and emerging bio/pharmaceutical firms. In the past 3 years, MME has completed more than 125 biopharma price strategies in...

OPEN Health is a family of specialist healthcare communications, access and real-world data practices with extensive experience and expertise in rare disease.  In a complex world of orphan treatment evidence, value, access and uptake we remove the...

Inceptua is a leading pharma, partner, and service company with focus on helping pharma and biotech companies throughout the product lifecycle, providing leading expertise in the three business areas Commercial Products, Medicine Access and Clinical ...

Dolon is a strategic market access consultancy for life sciences companies wanting to obtain reimbursement for their rare and severe disease medicines.  We take complex data and translate it into simple, evidence-based value propositions for...

IDEA specialises in providing pharmaceutical and biotech developers with Regulatory Affairs and EU legal representation for clinical trials and orphan drug designations (ODD). We offer a range of Regulatory Affairs services to help our clients...

Komtur Polska, as a part of an international group — Komtur Pharmaceuticals, represents fifty years of tradition on the pharmaceutical products market. We have been present on in Poland since 2005. Our actions focus on the distribution of...

Synteract is an innovative CRO providing full-service, Phase I-IV services to biopharma companies in bringing new medicines to market. We align our operational excellence, therapeutic expertise, and the right technology to support each client’s...

It is our goal at Ewopharma to bring much needed targeted treatments to patients in Central Eastern Europe (CEE) and Switzerland. Ewopharma is the bridge for pharmaceutical companies and brands from across the globe to access our markets. We are a...

At myTomorrows, we facilitate access to pre-approval medicines and provide information about treatment options to create better healthcare. myTomorrows provides physicians and their patients with unmet medical needs access to not-yet-licensed...

Pulse Infoframe Inc  is a new style of healthcare informatics company.  It’s platform solution, healthie™, empowers consortia of pharmaceutical companies, researchers, clinicians and patients, by aggregating information from a variety of sources and ...

Minoryx is a clinical stage biotech company leading the development of new therapies for X-ALD and other Orphan CNS diseases, a group of rare diseases of genetic origin with a high unmet medical need. The company’s leading program, a differentiated...

Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal...

Mezzion Inc is a company specialized in global new drug development process that generates profit through identifying new candidate drugs, developing the new drug up to a certain level in clinical trials (generally up to phase 2b) and licensing-out...